194 related articles for article (PubMed ID: 2089172)
1. Thrombocytopenia subsequently develops systemic lupus erythematosus--can anti-SS-A antibody predict the next event?
Adachi M; Mita S; Obana M; Matsuoka Y; Harada K; Irimajiri S
Jpn J Med; 1990; 29(5):481-6. PubMed ID: 2089172
[TBL] [Abstract][Full Text] [Related]
2. Lupoid thrombocytopenia.
Firkin BG; Buchanan RR; Pfueller S; Ryan P
Aust N Z J Med; 1987 Jun; 17(3):295-300. PubMed ID: 3499888
[TBL] [Abstract][Full Text] [Related]
3. [Idiopathic thrombocytopenic purpura as first manifestation of systemic lupus erythematosus lupus].
Balsalobre Aznar J; Herráez Herrera P; Porta Etessam J; Torres Martín C; Bermell Serrano JC; Núñez López R; Mateo Bernardo I; Padrino Martínez JM; Morillas López L
An Med Interna; 1999 Dec; 16(12):611-4. PubMed ID: 10686711
[TBL] [Abstract][Full Text] [Related]
4. Hypergammaglobulinemic purpura in systemic autoimmune rheumatic diseases: predictive value of anti-Ro(SSA) and anti-La(SSB) antibodies and treatment with indomethacin and hydroxychloroquine.
Senécal JL; Chartier S; Rothfield N
J Rheumatol; 1995 May; 22(5):868-75. PubMed ID: 8587074
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic importance of anti-Ro autoantibodies].
Dörner T; Hiepe F
Z Arztl Fortbild (Jena); 1992 Mar; 86(5):203-10. PubMed ID: 1585672
[No Abstract] [Full Text] [Related]
6. Fluorescent antinuclear antibodies and anti-SS-A/Ro in patients with immune thrombocytopenia subsequently developing systemic lupus erythematosus.
Anderson MJ; Peebles CL; McMillan R; Curd JG
Ann Intern Med; 1985 Oct; 103(4):548-50. PubMed ID: 3898952
[No Abstract] [Full Text] [Related]
7. [Anticytoplasmic antibodies (Ro and La) and connective tissue disease: clinical and biological heterogeneity of systemic lupus].
Guillet G; Gin H; Aubertin J
Sem Hop; 1983 Feb; 59(8):513-6. PubMed ID: 6302893
[No Abstract] [Full Text] [Related]
8. [Clinical significance of antinuclear antibody in patients with idiopathic thrombocytopenic purpura].
Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
Rinsho Ketsueki; 1992 Sep; 33(9):1178-82. PubMed ID: 1433939
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia.
Ahn SM; Choi EJ; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
Arthritis Res Ther; 2022 Sep; 24(1):213. PubMed ID: 36068638
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies.
Harley JB; Gaither KK
Rheum Dis Clin North Am; 1988 Apr; 14(1):43-56. PubMed ID: 2969602
[TBL] [Abstract][Full Text] [Related]
11. Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus.
Sánchez-Guerrero J; Lew RA; Fossel AH; Schur PH
Arthritis Rheum; 1996 Jun; 39(6):1055-61. PubMed ID: 8651971
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic significance and diagnostic value of lupus autoantibodies.
Tomer Y; Buskila D; Shoenfeld Y
Int Arch Allergy Immunol; 1993; 100(4):293-306. PubMed ID: 8481649
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of anti-Ro antibodies in autoimmune diseases].
Peters E; Kapelle A
Z Arztl Fortbild (Jena); 1992 Mar; 86(5):211-6. PubMed ID: 1585673
[No Abstract] [Full Text] [Related]
14. [Nine-year's follow up on the appearance of autoantibodies in a child with idiopathic thrombocytopenic purpura subsequently developing lupus with central nervous system manifestations].
Kagitani M; Makino S; Kinjo Y; Hirano S; Tabushi Y; Sasaki M; Takeuchi T; Hanafusa T; Murata T
Ryumachi; 2002 Jun; 42(3):591-6. PubMed ID: 12166113
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet antibody determination using platelet factor 3 assay in thrombocytopenic patients.
Chong LL
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Nov; 19(4):233-7. PubMed ID: 3816366
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism.
Nakamura M; Tanaka Y; Satoh T; Kawai M; Hirakata M; Kaburaki J; Kawakami Y; Ikeda Y; Kuwana M
Rheumatology (Oxford); 2006 Feb; 45(2):150-6. PubMed ID: 16188945
[TBL] [Abstract][Full Text] [Related]
17. Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes. Correlation with antinuclear antibodies and HLA class II alleles.
Perl A; Colombo E; Dai H; Agarwal R; Mark KA; Banki K; Poiesz BJ; Phillips PE; Hoch SO; Reveille JD
Arthritis Rheum; 1995 Nov; 38(11):1660-71. PubMed ID: 7488288
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases.
Robbins A; Hentzien M; Toquet S; Didier K; Servettaz A; Pham BN; Giusti D
Front Immunol; 2019; 10():444. PubMed ID: 30915082
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody determination in the diagnosis of systemic lupus erythematosus.
Kurien BT; Scofield RH
Scand J Immunol; 2006 Sep; 64(3):227-35. PubMed ID: 16918691
[TBL] [Abstract][Full Text] [Related]
20. Lupus pregnancy. II. Unusual pattern of hypocomplementemia and thrombocytopenia in the pregnant patient.
Lockshin MD; Harpel PC; Druzin ML; Becker CG; Klein RF; Watson RM; Elkon KB; Reinitz E
Arthritis Rheum; 1985 Jan; 28(1):58-66. PubMed ID: 3917671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
